shh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Clinical imatinib mesylate treatment induces early normalisation of aberrant neutrophil leukotriene C4 synthase expression and activity in chronic myeloid leukaemia
Show others and affiliations
2008 (English)In: British journal of haematology, ISSN 1365-2141, Vol. 142, no 6, p. 992-5Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2008. Vol. 142, no 6, p. 992-5
Keywords [en]
Leukotrien C4 synthase, Chronic myeloid leukaemia, Imatinib mesylate, Neutrophil, Philadelphia-chromosome
National Category
Hematology
Identifiers
URN: urn:nbn:se:shh:diva-52DOI: 10.1111/j.1365-2141.2008.07283.xPubMedID: 18573108OAI: oai:DiVA.org:shh-52DiVA, id: diva2:301954
Available from: 2010-03-03 Created: 2010-02-23 Last updated: 2020-06-02Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Kumlin, MariaLindgren, Jan Åke

Search in DiVA

By author/editor
Kumlin, MariaLindgren, Jan Åke
By organisation
Sophiahemmet University
Hematology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 324 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf